Federal settlement for thalidomide survivors gets court’s approval
OTTAWA — A federal judge has locked in a compensation program for Canadians born with birth defects because of the drug thalidomide.
Thalidomide was approved in Canada to treat morning sickness in pregnant women for less than a year in the early 1960s but it was available unofficially for several years both before and after that.
The drug caused major problems in fetuses, particularly shortened and malformed limbs, and in 1990, the Canadian government set up one program to help people living with the consequences.
In 2015, the federal government set up another, but it came under attack for demanding applicants prove they were eligible by supplying detailed documentation of things their mothers did more than 50 years before.